Tepotinib, also known as {MSC2156119|the developmental compound|this molecule), represents a novel breakthrough in the treatment of NSCLC, particularly in individuals harboring MET dysregulation. This specific tyrosine https://adamtoib085754.wikipublicity.com/8456409/tepotinib_a_comprehensive_investigation_into_msc2156119_and_its_potential